Featured Post
The Basics of Personalized Medicine: Why Automated Compounding Is Key to Its Future
Automated compounding represents the future of personalized medicine by transforming traditional pharmacy operations through precision, scalability, and quality control. While personalized medications currently account for only 1% of all prescriptions, pharmaceutical automation enables consistent production of customized dosages crucial for children, elderly patients, and specialized populations requiring tailored treatments.
3D-printed personalized meds are almost here, thanks to this Finnish startup
Pharmaceutical manufacturing is closely linked to mass production. In order for medicines to be sold cheaply, they often have to be made in huge amounts. But what happens if you need a drug in a different dose than what’s being sold? Or a different ingredient in the mix than what’s on offer?
Young citizens represent 100 % of the future of a healthy world
There’s a need for better paediatric medicines as young citizens represent 100 % of the future of a healthy world.
Reducing drug waste for a sustainable future
We think SUDDEN, a research project that aims at reducing the environmental hazards related to the life cycle of pharmaceuticals, is a great Finnish initiative.
3D printed drugs – science fiction or reality in the hospital pharmacy?
Are you visiting the ADKA-Jahrescongress in Nürnberg? Then don't miss the keynote-lecture of our Founder, Niklas Sandler Topelius about:
3D PRINTED DRUGS – SCIENCE-FICTION OR REALITY IN THE HOSPITAL PHARMACY?
.png)
Academic research behind CurifyLabs
Our concept is based on over 10 years of extensive research in the field of personalized medicines.
.png)
Meet Our Team - Interview With Anni Saukkonen
Our team has grown a lot the past months and we would like to introduce some of our newest team members. Today we meet Anni Saukkonen who has a hybrid role in our team, she's the link between R&D and our clients.
.png)
3D Printed Medicine In News
We think it's great to see 3D printing applications are getting more widely tested. This article was published in DI Life Science (18 of January, 2022) about the work of Christel Bergström on 3D printed medicines for better, safer and more efficient treatments of severely sick children.
Interview with Erik Haeffler, CEO, APL
Interview with Erik Haeffler on APL's role in developing personalized medicines for patients with unique needs using innovative CSS-technology.
How 3D Printing is Transforming Pharmaceuticals into More Precise, Effective Treatments
In this recent article, the future of 3D printed medicine in personalization of treatments is discussed. Here are some snap shots from the article.
Mass Customization of Medicines
Mass customization is required for optimal treatments of the future. This excellent article by Siiskonen, Malmqvist and Folestad (2021) describes the potentoal of mass customization.
Meet the team - interview with our CEO Charlotta
I’m a serial entrepreneur with a commercial background and I really like to learn new things and think outside of the box.
Potential Risks of Pharmacy Compounding
Why do we need quality assurance for pharmacy compounding in the future?